2.24 PM INFLUENZA A (H1 N1) ANTI-VIRUS VACCINATION! | |
After the series of dog vaccinations, the barangay recently conducted an Influenza A (H1 N1) anti-Virus Vaccination for human rare species (the senior citizens) last September 28, 2011 at the Barangay Health Center at the Groundfloor of the Barangay Hall which started at 1:00 p.m. because in the morning, it being Wednesday was the regular schedule for the immunization of infants such as DPT. Facilitating the vaccination was Ms. Emily Avergonzado - midwife/nurse together with the Barangay Volunteer Health Workers. Present also was the Committee chairman on Health & Social Services, Kagawad Erico R. Talili. Influenza A (H1N1) virus is a subtype of influenza A virus and was the most common cause of human influenza (flu) in 2009. Some strains of H1N1 are endemic in humans and cause a small fraction of allinfluenza-like illness and a small fraction of all seasonal influenza. H1N1 strains caused a few percent of all human flu infections in 2004–2005.[1] Other strains of H1N1 are endemic in pigs (swine influenza) and in birds (avian influenza). In June 2009, the World Health Organization declared the new strain of swine-origin H1N1 as a pandemic. This strain is often called swine flu by the public media. This novel virus spread worldwide and had caused about 17,000 deaths by the start of 2010. On August 10, 2010, the World Health Organization declared the H1N1 influenza pandemic over, saying worldwide flu activity had returned to typical seasonal patterns.[2] As of 26 April 2011, an H1N1 pandemic preparedness alert has been issued by the World Health Organisation (WHO) for the Americas. See Recombinomics- H1N1 WHO Alert 2011. The affected areas have included the Chihuahua region of Mexico where its severity and work load have been high. It is reported by the aforementioned Recombinomics source that the current vaccine (California/7/2009) for H1N1 influenza might be losing its effectiveness in 2011. This point is all the more significant since it is the current virus target for the northern hemisphere's flu vaccine, and is the intended choice for the southern hemisphere. Sec Red | |
|